News

Filter

Current filters:

DepomedResearch

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?

03-06-2013

US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Depomed says BREEZE 3 data for Serada shows benefits for hot flashes

04-10-2012

USA-based Depomed (Nasdaq: DEPO) is presenting two abstracts from its Phase III clinical trial, BREEZE…

DepomedMetabolicsPharmaceuticalResearchSeradaWomen's Health

Depomed shares plummet as Ph III Serada trial fails one endpoint

17-10-2011

Shares of US specialty drugmaker Depomed (Nasdaq: DEPO) fell 28.2% to $4.52 last Friday, after the company…

DepomedgabapentinNeurologicalPharmaceuticalResearchSerada

COMPANY SPOTLIGHT

Menarini

Back to top